Sbir phase i: stress pathway inhibition prevents covid-19 infection (covid-19)

Ended Project Grant Awarded Last action

Award ID
2035793
Recipient
Awarding agency
Obligated
$255,700

Award facts

Assistance listing
47.041 Engineering
Completion date
Place of performance
Gurnee, IL 60031, USA

Award details come from USAspending.gov.

About this award

Written by GovTribe AI ·

The National Science Foundation Division of Industrial Innovation awarded $255,700 to Creative Biotherapeutics LLC through its Engineering program (CFDA 47.041) on January 15, 2021 to fund the project "SBIR PHASE I: STRESS PATHWAY INHIBITION PREVENTS COVID-19 INFECTION (COVID-19)." This Project Grant will support Creative Biotherapeutics' research efforts through December 31, 2021 to develop inhibitors of stress response pathways to prevent COVID-19 infection. The NSF Engineering program seeks to foster innovation and excellence in engineering research, and this award advances that goal through Creative Biotherapeutics' work to address the COVID-19 pandemic.

Quick answers

Who received award 2035793?

2035793 was awarded to Creative Biotherapeutics LLC by Division of Industrial Innovation (National Science Foundation) on January 15, 2021.

How much is award 2035793 worth?

$255,700 has been obligated on 2035793.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login